000 -LEADER |
fixed length control field |
03433nam a22003974a 4500 |
001 - CONTROL NUMBER |
control field |
58526990 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
OCoLC |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20211001065237.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
050222s2005 paua b 001 0 eng |
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
LC control number |
2005271849 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
0323032869 |
035 ## - SYSTEM CONTROL NUMBER |
System control number |
.b2452864x |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
DLC |
Transcribing agency |
DLC |
Modifying agency |
SBH |
-- |
VAM |
-- |
NLM |
-- |
MBB |
-- |
IXA |
-- |
BAKER |
042 ## - AUTHENTICATION CODE |
Authentication code |
pcc |
050 00 - LIBRARY OF CONGRESS CALL NUMBER |
Classification number |
RM300 |
Item number |
.H86 2005 |
060 00 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
Classification number |
2005 E-843 |
060 10 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
Classification number |
QV 4 |
Item number |
H918 2005 |
082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
615.58 |
Edition number |
22 |
100 ## - MAIN ENTRY--PERSONAL NAME |
Personal name |
Minneman Kenneth P. |
245 00 - TITLE STATEMENT |
Title |
Brody's human pharmacology : |
Remainder of title |
molecular to clinical / |
Statement of responsibility, etc. |
editors, Kenneth P. Minneman, Lynn Wecker ; consulting editors, Joseph Larner, Theodrore M. Brody |
246 30 - VARYING FORM OF TITLE |
Title proper/short title |
Human pharmacology |
250 ## - EDITION STATEMENT |
Edition statement |
4th ed |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Place of publication, distribution, etc. |
Philadelphia, Pa. : |
Name of publisher, distributor, etc. |
Elsvier Mosby, |
Date of publication, distribution, etc. |
c2005 |
300 ## - PHYSICAL DESCRIPTION |
Extent |
xvii, 775 p. : |
Other physical details |
col. ill. ; |
Dimensions |
28 cm |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc. note |
Includes bibliographical references and index |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
Introduction and definitions -- Receptors and concentration-response relationships -- Absorption, distribution, metabolism, and elimination -- Clinical pharmacokinetics and issues in therapeutics -- Gene therapy and emerging molecular therapies -- Regulated drug development and usage -- Herbals and natural products -- Introduction to the autonomic nervous system -- Drugs affecting the parasympathetic nervous system and autonomic ganglia -- Drugs affecting the sympathetic nervous system -- Regulation of blood pressure by the autonomic nervous system -- Antihypertensive drugs -- Diuretics: drugs that increase the excretion of water and electrolytes -- Antiarrhythmic drugs -- Drugs to treat heart failure -- Vasodilators and nitric oxide synthase -- Prostaglandins and related autacoids -- Lipid-lowering drugs and atherosclerosis -- Drugs to treat blood disorders -- Introduction to the central nervous system -- Treatment of Parkinson's and Alzheimer's diseases -- Treatment of psychotic disorders -- Treatment of affective disorders -- Treatment of anxiety and sleep disorders -- Ethanol and related compounds -- Treatment of eating disorders and obesity -- Treatment of seizure disorders --General anesthetics -- Skeletal muscle relaxants -- Local anesthetics --Drugs to control pain -- Drug and substance abuse -- Glucocorticoids and mineralocorticoids -- Drugs to treat asthma and chronic obstructive pulmonary disease -- Estrogens and progestins -- Androgens and antiandrogens -- Thyroid and antithyroid drugs -- Insulin and drugs used in the therapy of diabetes mellitus -- Drugs affecting utrerine motility -- Hypothalamic-pituitary hormones -- Calcium-regulating hormones and other agents affecting bone -- Mechanisms of action of antineoplastic drugs -- Clinical effects of antineoplastic drugs -- Principles of antimicrobial use -- Bacterial cell wall inhibitors -- Inhibitors of bacterial ribosomal actions -- Bacterial folate antagonists, fluoroquinolones, and other antibacterial agents -- Selection of an antibacterial agent -- Antimycobacterial agents -- Antifungal agents -- Antiviral agents -- Drugs to treat parasitic infections -- Immunopharmacology -- Histamines and antihistamines -- Gastrointestinal drugs -- Toxicology |
600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME |
Source of heading or term |
pharmacology |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Pharmacology |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Chemotherapy |
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Pharmacology |
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Drug Therapy |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Brody, Theodore M |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Larner, Joseph, |
Dates associated with a name |
1921- |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Minneman, Kenneth P |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
|
Koha item type |
Books |